Literature DB >> 4538877

The prognosis of cryptogenic fibrosing alveolitis.

B H Stack, Y F Choo-Kang, B E Heard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4538877      PMCID： PMC470541          DOI： 10.1136/thx.27.5.535

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  16 in total

1.  INTERSTITIAL PULMONARY FIBROSIS.

Authors:  W B FORD; J W GIACOBINE; H R MADOFF; M SACHS
Journal:  J Thorac Cardiovasc Surg       Date:  1964-06       Impact factor: 5.209

2.  IDIOPATHIC INTERSTITIAL FIBROSIS OF THE LUNGS. I. PROGNOSIS AS INDICATED BY RADIOLOGICAL FINDINGS.

Authors:  L ANDER
Journal:  Acta Med Scand       Date:  1965-07

3.  Chronic diffuse interstitial fibrosis of the lungs.

Authors:  J G SCADDING
Journal:  Br Med J       Date:  1960-02-13

4.  Diffuse interstitial pulmonary fibrosis (Hamman-Rich syndrome) in an allergic patient: report of case.

Authors:  L TUFT; L S GIRSH
Journal:  Am J Med Sci       Date:  1958-01       Impact factor: 2.378

5.  Diffuse interstitial fibrosis of the lungs.

Authors:  M M SCHECHTER
Journal:  Am Rev Tuberc       Date:  1953-10

6.  Idiopathic diffuse interstitial lung disease. A review of 42 cases.

Authors:  B H Stack; I W Grant; W J Irvine; M A Moffat
Journal:  Am Rev Respir Dis       Date:  1965-12

7.  Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies.

Authors:  M Turner-Warwick; P Haslam
Journal:  Clin Allergy       Date:  1971-03

8.  Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis.

Authors:  J G Scadding; K F Hinson
Journal:  Thorax       Date:  1967-07       Impact factor: 9.139

9.  Carcinoma of the lung and diffuse interstitial pulmonary fibrosis.

Authors:  B Fox; R A Risdon
Journal:  J Clin Pathol       Date:  1968-07       Impact factor: 3.411

10.  Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer.

Authors:  R Haddad; D Massaro
Journal:  Am J Med       Date:  1968-08       Impact factor: 4.965
View more
  41 in total

Review 1.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

3.  Therapy of the idiopathic fibrosis of the lung.

Authors:  U H Cegla; R F Kroidl; J Meier-Sydow; C Thiel; G Czarnecki; F Schreiber
Journal:  Pneumonologie       Date:  1975-09-26

4.  Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis.

Authors:  D S Pratt; M I Schwartz; J J May; R B Dreisin
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

Review 5.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

6.  Synchronous double primary lung cancers of squamous and neuroendocrine type associated with cryptogenic fibrosing alveolitis.

Authors:  J W Seo; J G Im; Y W Kim; J H Kim; M N Sheppard
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

Review 7.  The donor lung: conservation of a precious resource.

Authors:  C A Keller
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

8.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.

Authors:  I D Johnston; R J Prescott; J C Chalmers; R M Rudd
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

9.  Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.

Authors:  D W Mapel; W C Hunt; R Utton; K B Baumgartner; J M Samet; D B Coultas
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

10.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.

Authors:  M A Johnson; S Kwan; N J Snell; A J Nunn; J H Darbyshire; M Turner-Warwick
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.